Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01853397 · ClinicalTrials.gov registry record · NA
Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method
A NA study, sponsored by Solta Medical.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT01853397 is a NA study that has completed, run by Solta Medical. The registered enrollment target is 72 participants.
The verdict
NCT01853397, a NA study, has completed, sponsored by Solta Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, efficacy, and tolerability of treatment with the Liposonix System (Model 2)using a single pass technique.
Interventions
- DEVICE Liposonix System (Model 2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01853397
The ClinicalTrials.gov registry entry for NCT01853397 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solta Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liposonix System (Model 2) is the first listed.
NCT01853397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01853397 about?
NCT01853397 is a clinical study titled "Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method". The purpose of this study is to evaluate the safety, efficacy, and tolerability of treatment with the Liposonix System (Model 2)using a single pass technique.
What is the current status of trial NCT01853397?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2013-04. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01853397?
The interventions under investigation include: Liposonix System (Model 2) (DEVICE).
Who is sponsoring clinical trial NCT01853397?
This trial is sponsored by Solta Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.